- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2168
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2168 companies
Lobe Sciences
Market Cap: CA$26.6m
A biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases.
LOBE
CA$0.08
7D
14.3%
1Y
77.8%
Fusion Antibodies
Market Cap: UK£14.1m
A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.
FAB
UK£0.11
7D
9.8%
1Y
-25.0%
CalciMedica
Market Cap: US$19.0m
A clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.
CALC
US$0.59
7D
-7.8%
1Y
-79.5%
AIxCrypto Holdings
Market Cap: US$19.0m
Focuses on building an ecosystem that integrates artificial intelligence and blockchain while bridging Web2 and Web3.
AIXC
US$0.93
7D
-29.4%
1Y
-49.7%
Control Bionics
Market Cap: AU$26.3m
Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.
CBL
AU$0.059
7D
-4.8%
1Y
55.3%
NewcelX
Market Cap: US$18.6m
A biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes.
NCEL
US$3.48
7D
2.7%
1Y
n/a
Rocket One
Market Cap: US$18.4m
Focuses on developing and commercializing AI semiconductor infrastructure.
RKTO
US$0.74
7D
-3.0%
1Y
-39.9%
NeuroScientific Biopharmaceuticals
Market Cap: AU$25.3m
Engages in the research and development of biomedical products targeting neurodegenerative conditions.
NSB
AU$0.065
7D
8.3%
1Y
-60.6%
Cyclerion Therapeutics
Market Cap: US$18.1m
A biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.
CYCN
US$4.00
7D
-2.9%
1Y
44.9%
Argenica Therapeutics
Market Cap: AU$25.0m
A biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia.
AGN
AU$0.20
7D
-4.9%
1Y
-70.9%
Scienture Holdings
Market Cap: US$17.8m
Operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.
SCNX
US$0.41
7D
-9.6%
1Y
-60.3%
Light AI
Market Cap: CA$24.5m
A healthcare technology company, focuses on the development of artificial intelligence and machine learning diagnostic digital healthcare solutions.
ALGO
CA$0.20
7D
-13.0%
1Y
-16.7%
Aptamer Group
Market Cap: UK£13.0m
Provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.
APTA
UK£0.0037
7D
7.1%
1Y
-54.8%
INOVIQ
Market Cap: AU$24.6m
Develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.
IIQ
AU$0.17
7D
-5.4%
1Y
-56.3%
Tempest Therapeutics
Market Cap: US$17.6m
A clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
TPST
US$1.11
7D
3.7%
1Y
-89.9%
Lexaria Bioscience
Market Cap: US$17.4m
Operates as a biotechnology company.
LEXX
US$11.60
7D
0.7%
1Y
-16.8%
Palatin Technologies
Market Cap: US$17.2m
A biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.
0KF3
US$9.69
7D
-9.4%
1Y
40.8%
Lipocine
Market Cap: US$17.0m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology.
LPCN
US$2.15
7D
5.4%
1Y
-30.6%
Pasithea Therapeutics
Market Cap: US$16.9m
A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.
KTTA
US$0.56
7D
12.5%
1Y
-20.4%
Pluri
Market Cap: US$16.8m
A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries.
PLUR
US$1.66
7D
1.8%
1Y
-67.9%
Finch Therapeutics Group
Market Cap: US$16.4m
A clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
FNCH.Q
US$10.20
7D
0%
1Y
-16.7%
Firefly Neuroscience
Market Cap: US$16.3m
An artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America.
AIFF
US$1.03
7D
-5.5%
1Y
-62.0%
Medicus Pharma
Market Cap: US$16.3m
A biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States.
MDCX
US$0.26
7D
-0.9%
1Y
-87.2%
BioVie
Market Cap: US$16.1m
A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.
BIVI
US$2.09
7D
116.7%
1Y
32.3%
Psyence Biomedical
Market Cap: US$16.1m
An integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines.
PBM
US$4.27
7D
-4.5%
1Y
-78.6%
BioCardia
Market Cap: US$16.0m
A clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.
BCDA
US$1.13
7D
15.8%
1Y
-42.3%
Oncotelic Therapeutics
Market Cap: US$16.0m
A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States.
OTLC
US$0.033
7D
-15.2%
1Y
-35.1%
Algorae Pharmaceuticals
Market Cap: AU$22.3m
A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.
1AI
AU$0.011
7D
-8.3%
1Y
37.5%
Lisata Therapeutics
Market Cap: US$15.9m
A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
LSTA
US$1.74
7D
51.3%
1Y
-30.7%
Citius Pharmaceuticals
Market Cap: US$15.8m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$0.60
7D
5.6%
1Y
-54.3%
Vyome Holdings
Market Cap: US$15.7m
A clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States.
HIND
US$2.23
7D
-1.8%
1Y
-80.2%
Chemomab Therapeutics
Market Cap: US$15.7m
A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases.
CMMB
US$2.30
7D
20.4%
1Y
-32.4%
Intensity Therapeutics
Market Cap: US$15.5m
A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States.
INTS
US$4.90
7D
16.3%
1Y
-35.1%
Inhibitor Therapeutics
Market Cap: US$15.5m
A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.
INTI
US$0.089
7D
0%
1Y
53.7%
Genflow Biosciences
Market Cap: UK£11.3m
Engages in the research and development of gene therapies in the United Kingdom, Belgium, and the United States.
GENF
UK£0.02
7D
0%
1Y
207.7%
Exlites Holdings International
Market Cap: US$15.4m
Manufactures and distributes medical products.
EXHI
US$0.35
7D
-2.8%
1Y
n/a